A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers

PURPOSE: To evaluate the ocular safety of OTX-101 0.09% – a novel, nanomicellar, clear, aqueous solution of cyclosporine (CsA) – and to determine the systemic exposure to CsA following ophthalmic administration. PATIENTS AND METHODS: Healthy volunteers ≥18 years of age were recruited for participati...

Descripción completa

Detalles Bibliográficos
Autores principales: Karpecki, Paul M, Weiss, Sidney L, Kramer, William G, O’Connor, Patrick, Evans, David, Johnston, Josh, Jasper, April L, Justice, Angela, Ogundele, Abayomi B, Devries, Doug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454998/
https://www.ncbi.nlm.nih.gov/pubmed/31040639
http://dx.doi.org/10.2147/OPTH.S187945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454998/
https://www.ncbi.nlm.nih.gov/pubmed/31040639
http://dx.doi.org/10.2147/OPTH.S187945

Ejemplares similares